20-HETE regulates the angiogenic functions of human endothelial progenitor cells and contributes to angiogenesis in vivo

Journal of Pharmacology and Experimental Therapeutics

Volumn 348, Issue 3, 2014, Pages 442-451

  Chen, Li ^a,b   Ackerman, Rachel ^b   Saleh, Mohamed ^b   Gotlinger, Katherine H ^b   Kessler, Michael ^c   Mendelowitz, Lawrence G ^d   Falck, John R ^e   Arbab, Ali S ^f   Scicli, A Guillermo ^f   Schwartzman, Michal L ^b   Yang, Jing ^a   Guo, Austin M ^a,b  

^a WUHAN UNIVERSITY   (China)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c WESTCHESTER MEDICAL CENTER   (United States)

^d Phelps Memorial Hospital Center   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; CHEMOKINE RECEPTOR CXCR4; FIBRONECTIN; HEMOGLOBIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL ADHESION; CELL HOMING; CELL PROLIFERATION; CONTROLLED STUDY; CYP4A11 GENE; ENDOTHELIAL PROGENITOR CELL; FATTY ACID SYNTHESIS; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROVASCULARIZATION; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; CELL ADHESION; CELL HYPOXIA; CELL PROLIFERATION; CYTOCHROME P-450 ENZYME SYSTEM; ENDOTHELIUM, VASCULAR; FEEDBACK, PHYSIOLOGICAL; FEMALE; FIBRONECTINS; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; INTEGRIN ALPHA4BETA1; MICE; MICE, INBRED BALB C; MICROVESSELS; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, CXCR4; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84896737242     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.113.210120     Document Type: Article

References (47)

1. Amaral SL, Maier KG, Schippers DN, Roman RJ, and Greene AS (2003) CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis. Am J Physiol Heart Circ Physiol 284:H1528-H1535.
2. Arbab AS, Janic B, Knight RA, Anderson SA, Pawelczyk E, Rad AM, Read EJ, Pandit SD, and Frank JA (2008) Detection of migration of locally implanted AC1331 stem cells by cellular magnetic resonance imaging with histological findings. FASEB J 22:3234-3246.
3. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, and Isner JM (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221-228.
4. Burger JA and Kipps TJ (2006) CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107:1761-1767.
5. Caiado F and Dias S. (2012) Endothelial progenitor cells and integrins: adhesive needs. Fibrogenesis Tissue Repair 5:4.
6. Carroll MA, Balazy M, Huang DD, Rybalova S, Falck JR, and McGiff JC (1997) Cytochrome P450-derived renal HETEs: storage and release. Kidney Int 51: 1696-1702.
7. Cencioni C, Capogrossi MC, and Napolitano M (2012) The SDF-1/CXCR4 axis in stem cell preconditioning. Cardiovasc Res 94:400-407.
8. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, and Gurtner GC (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10:858-864.
9. Ceradini DJ and Gurtner GC (2005) Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med 15:57-63.
10. Chan BM, Elices MJ, Murphy E, and Hemler ME (1992) Adhesion to vascular cell adhesion molecule 1 and fibronectin. Comparison of alpha 4 beta 1 (VLA-4) and alpha 4 beta 7 on the human B cell line JY. J Biol Chem 267:8366-8370.
11. Chen P, Guo M, Wygle D, Edwards PA, Falck JR, Roman RJ, and Scicli AG (2005) Inhibitors of cytochrome P450 4A suppress angiogenic responses. Am J Pathol 166: 615-624.
12. Chen L, Ackerman R, and Guo AM (2012) 20-HETE in neovascularization. Prostaglandins Other Lipid Mediat 98:63-68.
13. De Falco E, Porcelli D, Torella AR, Straino S, Iachininoto MG, Orlandi A, Truffa S, Biglioli P, Napolitano M, and Capogrossi MC, et al. (2004) SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 104:3472-3482.
14. De La Luz Sierra M, Yang F, Narazaki M, Salvucci O, Davis D, Yarchoan R, Zhang HH, Fales H, and Tosato G (2004) Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood 103: 2452-2459.
15. Guo M, Roman RJ, Falck JR, Edwards PA, and Scicli AG (2005) Human U251 glioma cell proliferation is suppressed by HET0016 [N-hydroxy-N'-(4-butyl-2- methylphenyl)formamidine], a selective inhibitor of CYP4A. J Pharmacol Exp Ther 315:526-533.
16. Guo AM, Arbab AS, Falck JR, Chen P, Edwards PA, Roman RJ, and Scicli AG (2007) Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation. J Pharmacol Exp Ther 321:18-27.
17. Guo AM, Scicli G, Sheng J, Falck JC, Edwards PA, and Scicli AG (2009) 20-HETE can act as a nonhypoxic regulator of HIF-1alpha in human microvascular endothelial cells. Am J Physiol Heart Circ Physiol 297:H602-H613.
18. Guo AM, Janic B, Sheng J, Falck JR, Roman RJ, Edwards PA, Arbab AS, and Scicli AG (2011) The cytochrome P450 4A/F-20-hydroxyeicosatetraenoic acid system: a regulator of endothelial precursor cells derived from human umbilical cord blood. J Pharmacol Exp Ther 338:421-429.
19. Harris DT and Rogers I (2007) Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine. Curr Stem Cell Res Ther 2:301-309.
20. Hidalgo A, Sanz-Rodríguez F, Rodríguez-Fernández JL, Albella B, Blaya C, Wright N, Cabañas C, Prósper F, Gutierrez-Ramos JC, and Teixidó J (2001) Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells. Exp Hematol 29:345-355.
21. Hoenig MR, Bianchi C, and Sellke FW (2008) Hypoxia inducible factor-1 alpha, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: a unifying hypothesis. Curr Drug Targets 9:422-435.
22. Inoue K, Sodhi K, Puri N, Gotlinger KH, Cao J, Rezzani R, Falck JR, Abraham NG, and Laniado-Schwartzman M (2009) Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE. Am J Physiol Renal Physiol 297:F875-F884.
23. Janic B, Guo AM, Iskander AS, Varma NR, Scicli AG, and Arbab AS (2010) Human cord blood-derived AC1331 progenitor cells preserve endothelial progenitor characteristics after long term in vitro expansion. PLoS ONE 5:e9173.
24. Jarajapu YP and Grant MB (2010) The promise of cell-based therapies for diabetic complications: challenges and solutions. Circ Res 106:854-869.
25. Jiang M, Mezentsev A, Kemp R, Byun K, Falck JR, Miano JM, Nasjletti A, Abraham NG, and Laniado-Schwartzman M (2004) Smooth muscle-specific expression of CYP4A1 induces endothelial sprouting in renal arterial microvessels. Circ Res 94: 167-174.
26. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, and Asahara T (2000) Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97: 3422-3427.
27. Kirton JP and Xu Q (2010) Endothelial precursors in vascular repair. Microvasc Res 79:193-199.
28. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, and Itescu S (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7:430-436.
29. Kucia M, Jankowski K, Reca R, Wysoczynski M, Bandura L, Allendorf DJ, Zhang J, Ratajczak J, and Ratajczak MZ (2004) CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35:233-245.
30. Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P, and Young PP (2006) VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J 20: 1495-1497.
31. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, and Witte L, et al. (2001) Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7:1194-1201.
32. Miyata N and Roman RJ (2005) Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system. J Smooth Muscle Res 41:175-193.
33. Murohara T (2001) Therapeutic vasculogenesis using human cord blood-derived endothelial progenitors. Trends Cardiovasc Med 11:303-307.
34. Oostendorp RA and Dörmer P (1997) VLA-4-mediated interactions between normal human hematopoietic progenitors and stromal cells. Leuk Lymphoma 24:423-435.
35. Peled A, Kollet O, Ponomaryov T, Petit I, Franitza S, Grabovsky V, Slav MM, Nagler A, Lider O, and Alon R, et al. (2000) The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(1) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 95: 3289-3296.
36. Qin J, Chen X, Xie X, Tsai MJ, and Tsai SY (2010) COUP-TFII regulates tumor growth and metastasis by modulating tumor angiogenesis. Proc Natl Acad Sci USA 107:3687-3692.
37. Rosti V, Massa M, Campanelli R, De Amici M, Piccolo G, and Perfetti V (2007) Vascular endothelial growth factor promoted endothelial progenitor cell mobilization into the peripheral blood of a patient with POEMS syndrome. Haematologica 92:1291-1292.
38. Rüegg C, Postigo AA, Sikorski EE, Butcher EC, Pytela R, and Erle DJ (1992) Role of integrin alpha 4 beta 7/alpha 4 beta P in lymphocyte adherence to fibronectin and VCAM-1 and in homotypic cell clustering. J Cell Biol 117:179-189.
39. Salvucci O, Yao L, Villalba S, Sajewicz A, Pittaluga S, and Tosato G (2002) Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 99:2703-2711.
40. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, and Asahara T (1999) Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5: 434-438.
41. Tepper OM, Capla JM, Galiano RD, Ceradini DJ, Callaghan MJ, Kleinman ME, and Gurtner GC (2005) Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 105: 1068-1077.
42. Urbich C and Dimmeler S (2004) Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95:343-353.
43. Urbich C, Heeschen C, Aicher A, Dernbach E, Zeiher AM, and Dimmeler S (2003) Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108:2511-2516.
44. Urbich C, Aicher A, Heeschen C, Dernbach E, Hofmann WK, Zeiher AM, and Dimmeler S (2005) Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 39:733-742.
45. Vajkoczy P, Blum S, Lamparter M, Mailhammer R, Erber R, Engelhardt B, Vestweber D, and Hatzopoulos AK (2003) Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J Exp Med 197:1755-1765.
46. Wang MH, Brand-Schieber E, Zand BA, Nguyen X, Falck JR, Balu N, and Schwartzman ML (1998) Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors. J Pharmacol Exp Ther 284:966-973.
47. Williams JM, Murphy S, Burke M, and Roman RJ (2010) 20- hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension. J Cardiovasc Pharmacol 56: 336-344.